Guest Editor: G. Castaman GENE THERAPY FOR HEMOPHILIA: FACTS AND QUANDARIES IN THE 21ST CENTURY
Therapy for hemophilia has evolved in the last 40 years from plasma-based concentrates to recombinant proteins and, more recently, to non-factor therapeutics. Along this same timeline, research in adeno-associated virus (AAV) based gene therapy vectors has provided the framework for successful early...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
PAGEPress Publications
2020-08-01
|
| Collection: | Mediterranean Journal of Hematology and Infectious Diseases |
| Accès en ligne: | https://www.mjhid.org/index.php/mjhid/article/view/4255 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|